Strides Pharma Science Ltd.

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1990

Chairman: Arun Kumar

Managing Director: R Ananthanarayanan

Group: --

Listing: NSE: STAR, BSE: 532531

Headquarters: Navi Mumbai, Maharashtra

Website: www.stridesarco.com

Market cap: R 6,591.07 Cr

Revenue (TTM): R 2,847.97 Cr

Earnings (TTM): R 239.89 Cr

Cash: R 356.07 Cr

Total Debt: R 1,961.74 Cr

Promoters' ownership: 29.69%

Liquidity: High

52 Week range: R 268.00 - 764.60

Face value: R10.00

Shares outstanding: 8,96,25,664

10 Years Aggregate:

• CFO: 1,540.30 Cr
• EBITDA: 3,310.25 Cr
• Net Profit: 2,900.34 Cr